Cell and Organ Transplantology. 2021; 9(2):96-102.
Evaluation of in vitro biocompatibility of scaffolds for the repair of bone defects
- 1R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine
- 2State Institute of Traumatology and Orthopedics, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
- 3M. I. Pyrogov Vinnytsia Regional Clinical Hospital, Vinnytsia , Ukraine
The use of bone scaffolds in traumatology and orthopedics is an extremely important issue. The growing number of cases of significant bone defects, in particular after revision arthroplasty, combat trauma and due to the introduction of new methods of reconstructive surgery of bones and joints, requires more detailed studies of the using different osteoplastic materials.
Materials and methods. As scaffolds used 4 types of materials that are most often used in the clinic for the correction of bone defects – ceramic hydroxylapatite, beta-tricalcium phosphate, allogeneic bone matrix treated with gamma irradiation, allogeneic bone matrix scaffold. The effect of matrices on the viability of normal human fibroblasts (M19 cell line) in cell culture in vitro was studied. The viability of cells after their co-cultivation with scaffolds was determined by colorimetric method by staining with crystal violet. To obtain an osteoinductive effect used platelet-rich plasma (PRP), standardized by the method of Araki with some modifications. The proliferative activity of fibroblasts was assessed by the level of expression of the proliferation marker Ki-67 by immunocytochemical analysis.
Results. It was found that the least pronounced antiproliferative effect is shown by allogeneic bone matrix treated with gamma irradiation. Data on the complex effect of co-cultivation of fibroblasts with scaffolds in the presence of PRP on cell viability and proliferative activity were obtained. It was found that PRP improves the survival of fibroblasts by 15-30 % and increases their proliferative activity by 35-75 %. Delipidization with 70 % ethyl alcohol for allogeneic bone matrix scaffolds, heat-treated by local bone bank technology, increased its biocompatibility with human fibroblasts.
Conclusions. According to the results of a comparative analysis of the impact of different scaffolds on the viability of normal human fibroblasts, it was found that scaffolds from allogeneic bone matrix have the least pronounced antiproliferative effect. Platelet-rich plasma has been shown to improve fibroblast survival and increase their proliferative activity.
Key words: scaffold; allogeneic bone matrix; platelet-rich plasma; tissue engineeringFull Text PDF
|1. Chocholata P, Kulda V, Babuska V. Fabrication of Scaffolds for Bone-Tissue Regeneration. Materials. 2019; 12:568.
|2. Dhandayuthapani B, Yoshida Y, Maekawa T, Kumar DS. Polymeric scaffolds in tissue engineering application: A review. Int J Polym Sci. 2011.
|3. Bouet G, Marchat D, Cruel M, Malaval L, Vico, L. In vitro three-dimensional bone tissue models: from cells to controlled and dynamic environment. Tissue Eng B Rev. 2015; 21:133-156.
|4. Henkel M, Woodruff D, Epari R, Glatt V, Dickinson I, Choong P, et al. Bone regeneration based on tissue engineering conceptions -a 21st century perspective. Bone Res. 2013; 1:216-248.
|5. Roseti L, Parisi V, Petretta M, et al. Scaffolds for Bone Tissue Engineering: State of the art and new perspectives. Mater Sci Eng C. 2017; 78:1246-1262.
|6. Qian Y, Han Q, Chen W, et al. Platelet-Rich Plasma Derived Growth Factors Contribute to Stem Cell Differentiation in Musculoskeletal Regeneration. Front Chem. 2017; 5:89.
|7. Rubina A, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018; 4:18-24.
|8. Wasterlain A, Braun B, Hillary J, Jason B, Dragoo L. Contents and Formulations of Platelet-Rich Plasma. Oper Tech Orthop. 2012; 22(1):33-42.
|9. Bobro L. Fibroblasts and their significance in tissue reactions. Arkhiv Patologii. 1990; 52(12): 65-8.|
|10. Zárate-Kalfópulos B, Reyes-Sánchez A. Injertos óseos en cirugía ortopédica [Bone grafts in orthopedic surgery]. Cir Cir. 2006; 74(3):217-22. [in Spanish].|
|11. Harsini S, Oryan A. Bone Grafting and the Materials for Using in Orthopedics Bone Grafting and the Materials for Using in Orthopedics. EC Orthopaedics. 2018; 9(12):1-12.|
|12. Gaiko G, Gerasymenko S, Holiuk Ye. Principles of making allografts using the local bone bank technology. Bulletin of Orthopedics Traumatology and Prosthetics. 2019; 1:68-78. [In Ukrainian]|
|13. Nguyen H, Morgan D, Forwood M. Sterilization of allograft bone: effects of gamma irradiation on allograft biology and biomechanics. Cell Tissue Bank. 2007; 8(2):93-105.
|14. Frommelt L, Gürtler L, Garrel T. Disinfection of femoral heads for bone grafting using the marburg bone bank system (lobator sd 1): a retrospective evaluation of quality control in the endo-klinik bone bank. Advances in Tissue Banking. 2004; 2004:339-351
|15. Pruss A, Seibold M, Benedix F. Validation of the Marburg bone bank system’ for thermodisinfection of allogenic femoral head transplants using selected bacteria, fungi, and spores. Biologicals. 2004; 31(4):287-94.
|16. Goliuk Ye, Yavorovska V, Bezdeneznykh N, Kozak T, Saulenko K. TGF-β1 level in platelet-rich plasma in patients with diseases and injuries of the musculoskeletal system. Cell and Organ Transplantology. 2019; 7(2):108-118.
|17. Fedoroff S, Richardson A. Colony Cultures. In: Protocols for Neural Cell Culture. Springer Protocols Handbooks. Humana Press. 2001. pp 307-315.
|18. Araki J, Jona M, Eto H, et al. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng. 18:176-185.
|19. Yavorovska V, Goliuk Ye, Magomedov O, et al. The blood cells count in leukocyte and leukocyte-poor platelet-concentrated plasma in patients with musculoskeletal disorders. Cell and Organ Transplantology. 2020; 8(1):13-19.
|20. Vega-Avila E, Pugsley K. An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. Proc West Pharmacol Soc. 2011; 54:10-4.|
|21. McCelland R, Wilson D, Leake R. A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. Eur J Cancer. 1991; 27:711-715.
|22. Finoli A, Schmelzer E, Over P, Nettleship I, Gerlach J. Open-Porous Hydroxyapatite Scaffolds for Three-Dimensional Culture of Human Adult Liver Cells. Tissue Engineering: From Basic Sciences to Clinical Perspectives. 2016; Article ID 604014.
|23. Eckl P, Whitcomb W, Michalopoulos G, Jirtle R. Effects of EGF and calcium on adult parenchymal hepatocyte proliferation. J Cell Physiol. 1987; 132(2):363-366.
|24. Moreau M, Gallois Y, Baslé M, Chappard D. Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells. Biomaterials. 2000; 21: 369-376. PMID: 10656318
|25. Gardin Ch, Ricci S, Ferroni L. Decellularization and Delipidation Protocols of Bovine Bone and Pericardium for Bone Grafting and Guided Bone Regeneration Procedures. Plose One. 2015.
|26. Straum O. The optimal platelet concentration in platelet-rich plasma for proliferation of human cells in vitro-diversity, biases, and possible basic experimental principles for further research in the field: A review. PeerJ. 2020; 8:e10303.
|27. Chappard D, Fressonnet C, Genty C, Baslé M, Rebel A. Fat in bone xenografts: importance of the purification procedures on cleanliness, wettability and biocompatibility. Biomaterials. 1993; 14: 507-512. PMID: 8329523
|28. Kazakova V, Novikov O, Zhilyakova E, et al. Prospects for the use of growth factors in bone regeneration. Review. The result of the study. Medicine and Pharmacy Series. 2015; 1(3):151-158 [In Russian].
|29. Pelipenko L, Sergienko A, Ivashev M. Effects of transforming growth factor beta-1. Int J Exp Samples. 2015; 3:558-559. [In Russian]|
Bezdieniezhnykh N, Holiuk Ye, Gerasymenko S, Saulenko K, Mayko V, Lykhova O. Evaluation of in vitro biocompatibility of scaffolds for the repair of bone defects. Cell Organ Transpl. 2021; 9(2):96-102. doi:10.22494/cot.v9i2.128